ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Evommune
10.07
-0.3600
-3.45%
成交量：
23.99萬
成交額：
240.60萬
市值：
3.65億
市盈率：
-3.86
高：
10.31
開：
10.31
低：
9.83
收：
10.43
52周最高：
33.20
52周最低：
9.83
股本：
3,629.21萬
流通股本：
1,998.20萬
量比：
0.25
換手率：
1.20%
股息：
- -
股息率：
- -
每股收益(TTM):
-2.6090
每股收益(LYR):
-11.2228
淨資產收益率：
-52.11%
總資產收益率：
-31.99%
市淨率：
1.32
市盈率(LYR):
-0.90
資料載入中...
總覽
公司
新聞資訊
公告
Evommune股價大跌11.3%
每日经济新闻
·
09/09
BUZZ——美國股市動態-Meta、Chime Financial、ServiceTitan
路透中文
·
09/09
Evommune盤前股價下跌18.1%，此前公司研發的濕疹藥物未達到中期試驗主要終點。
智通财经
·
09/09
Evommune因臨床試驗失敗放棄濕疹藥物開發，股價暴跌
路透中文
·
09/09
尼德姆證券首次覆蓋Evommune；股價上漲
路透中文
·
08/27
Evommune蕁麻疹藥物2b期研究未達主要終點 將轉向特應性皮炎與偏頭痛
环球市场播报
·
06/30
Evommune股價暴跌，因皮膚病藥物中期試驗失敗
路透中文
·
06/29
Evommune公布Evo756針對中重度慢性自發性蕁麻疹的2b期試驗頂線結果
美股速递
·
06/29
Evommune公司提交招股説明書：現有股東擬轉售最多450萬股普通股
美股速递
·
04/18
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/EVMN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EVMN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVMN\",,,,,undefined,":{"symbol":"EVMN","market":"US","secType":"STK","nameCN":"Evommune","latestPrice":10.07,"timestamp":1789496039784,"preClose":10.43,"halted":0,"volume":239923,"delay":0,"changeRate":-0.034515819750719025,"floatShares":19982000,"shares":36292113,"eps":-2.609,"marketStatus":"交易中","change":-0.36,"latestTime":"09-15 14:14:00 EDT","open":10.31,"high":10.31,"low":9.83,"amount":2406035.655818,"amplitude":0.046021,"askPrice":10.08,"askSize":100,"bidPrice":10.06,"bidSize":14,"shortable":3,"etf":0,"ttmEps":-2.609,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"listingDate":1762405200000,"exchange":"NYSE","adjPreClose":10.43,"postHourTrading":{"tag":"盘后","latestPrice":10.43,"preClose":10.43,"latestTime":"19:30 EDT","volume":4195,"amount":43753.85,"timestamp":1789428606826,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.246706,"impliedVol":1.8894,"impliedVolPercentile":0.87},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVMN\",,,,,undefined,":{"symbol":"EVMN","floatShares":19982000,"roa":"-31.99%","roe":"-52.11%","lyrEps":-11.222761,"volumeRatio":0.246706,"shares":36292113,"dividePrice":0,"high":10.31,"amplitude":0.046021,"preClose":10.43,"low":9.83,"week52Low":9.83,"pbRate":"1.32","psRate":"36.55","week52High":33.2,"institutionHeld":0,"latestPrice":10.07,"committee":-0.754386,"eps":-2.609,"divideRate":0,"volume":239923,"delay":0,"ttmEps":-2.609,"open":10.31,"prevYearClose":17.12,"prevWeekClose":10.54,"prevMonthClose":12.66,"prevQuarterClose":13.29,"fiveDayClose":13.08,"twentyDayClose":14.25,"sixtyDayClose":21.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EVMN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"EVMN","fiscalQuarterEnding":"2026/06","expectedEps":-0.68,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.89},{"market":"US","date":"2026-05-07","symbol":"EVMN","fiscalQuarterEnding":"2026/03","expectedEps":-0.83,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2026-03-05","symbol":"EVMN","fiscalQuarterEnding":"2025/12","expectedEps":-0.82,"name":null,"time":"盤後","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-1.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EVMN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EVMN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5833,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1787976000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EVMN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EVMN","date":"2026-09-14","current":-3.859716,"percent":1,"low":-16.229076,"twenty":-12.362455,"median":-9.690151,"eighty":-6.129859,"high":-4.040635,"avg":-9.630477,"sd":2.98647,"marketCap":382518871},"quantilePoints":[{"date":"2025-11-07","current":-9.395174,"twenty":-7.823584,"median":-7.430686,"eighty":-7.430686,"marketCap":608469038},{"date":"2025-11-14","current":-8.461694,"twenty":-9.04686,"median":-8.505813,"eighty":-7.430686,"marketCap":548013143},{"date":"2025-11-21","current":-8.689259,"twenty":-9.04686,"median":-8.689259,"eighty":-7.430686,"marketCap":562751147},{"date":"2025-11-28","current":-9.618094,"twenty":-9.051504,"median":-8.707835,"eighty":-8.049291,"marketCap":622906267},{"date":"2025-12-05","current":-10.184684,"twenty":-9.618094,"median":-8.986487,"eighty":-8.483986,"marketCap":659600890},{"date":"2025-12-12","current":-9.657505,"twenty":-9.633858,"median":-9.000419,"eighty":-8.483986,"marketCap":592227156},{"date":"2025-12-19","current":-7.716136,"twenty":-9.618094,"median":-8.986487,"eighty":-8.244704,"marketCap":473176635},{"date":"2025-12-26","current":-9.042428,"twenty":-9.528926,"median":-9.016673,"eighty":-8.355807,"marketCap":554508795},{"date":"2026-01-02","current":-8.800817,"twenty":-9.392482,"median":-9.003431,"eighty":-8.469125,"marketCap":539692472},{"date":"2026-01-09","current":-9.37143,"twenty":-9.380689,"median":-8.972554,"eighty":-8.293747,"marketCap":574684215},{"date":"2026-01-16","current":-10.075701,"twenty":-9.649623,"median":-9.019686,"eighty":-8.354639,"marketCap":617872222},{"date":"2026-01-23","current":-9.710714,"twenty":-9.690151,"median":-9.037572,"eighty":-8.461694,"marketCap":595490116},{"date":"2026-01-30","current":-11.129537,"twenty":-9.775997,"median":-9.042428,"eighty":-8.498847,"marketCap":682496613},{"date":"2026-02-06","current":-8.564346,"twenty":-9.775997,"median":-9.064213,"eighty":-8.549933,"marketCap":525191389},{"date":"2026-02-13","current":-14.332171,"twenty":-9.885497,"median":-9.065437,"eighty":-8.563866,"marketCap":878891712},{"date":"2026-02-20","current":-14.769127,"twenty":-10.094711,"median":-9.253195,"eighty":-8.56425,"marketCap":905687191},{"date":"2026-02-27","current":-13.689588,"twenty":-10.579486,"median":-9.338016,"eighty":-8.621921,"marketCap":839486596},{"date":"2026-03-06","current":-11.484529,"twenty":-11.200535,"median":-9.381712,"eighty":-8.67867,"marketCap":790939493},{"date":"2026-03-13","current":-12.018327,"twenty":-12.245567,"median":-9.479385,"eighty":-8.689259,"marketCap":827702188},{"date":"2026-03-20","current":-12.321662,"twenty":-12.396972,"median":-9.618094,"eighty":-8.70412,"marketCap":848592844},{"date":"2026-03-27","current":-12.379191,"twenty":-12.362455,"median":-9.695292,"eighty":-8.728757,"marketCap":852554865},{"date":"2026-04-02","current":-11.725452,"twenty":-12.336306,"median":-9.710846,"eighty":-8.771001,"marketCap":807531900},{"date":"2026-04-10","current":-14.983685,"twenty":-12.570606,"median":-9.775997,"eighty":-8.798761,"marketCap":1031926357},{"date":"2026-04-17","current":-14.000462,"twenty":-13.015147,"median":-9.975459,"eighty":-8.828576,"marketCap":964211818},{"date":"2026-04-24","current":-13.514081,"twenty":-13.425068,"median":-10.075701,"eighty":-8.877926,"marketCap":930714732},{"date":"2026-05-01","current":-12.44718,"twenty":-13.370677,"median":-10.26642,"eighty":-8.898489,"marketCap":857237253},{"date":"2026-05-08","current":-11.767292,"twenty":-13.351187,"median":-10.76455,"eighty":-8.934568,"marketCap":810413370},{"date":"2026-05-15","current":-10.76944,"twenty":-13.300701,"median":-10.81684,"eighty":-8.966981,"marketCap":818337411},{"date":"2026-05-22","current":-11.162865,"twenty":-13.208546,"median":-10.76944,"eighty":-8.989273,"marketCap":848232660},{"date":"2026-05-29","current":-11.058584,"twenty":-13.135327,"median":-10.864241,"eighty":-9.002829,"marketCap":840308618},{"date":"2026-06-05","current":-9.807205,"twenty":-13.084182,"median":-10.80499,"eighty":-9.017037,"marketCap":745220116},{"date":"2026-06-12","current":-9.807205,"twenty":-13.030837,"median":-10.755219,"eighty":-9.036643,"marketCap":745220116},{"date":"2026-06-18","current":-9.788245,"twenty":-12.946112,"median":-10.53322,"eighty":-9.042258,"marketCap":743779381},{"date":"2026-06-26","current":-11.43779,"twenty":-12.867664,"median":-10.624868,"eighty":-9.042428,"marketCap":869123316},{"date":"2026-07-02","current":-6.07677,"twenty":-12.855112,"median":-10.547048,"eighty":-9.032928,"marketCap":461755529},{"date":"2026-07-10","current":-6.403835,"twenty":-12.813273,"median":-10.376014,"eighty":-8.958621,"marketCap":486608205},{"date":"2026-07-17","current":-5.550622,"twenty":-12.635456,"median":-10.177718,"eighty":-8.800817,"marketCap":421775136},{"date":"2026-07-24","current":-5.36576,"twenty":-12.598847,"median":-10.075701,"eighty":-8.689259,"marketCap":407727971},{"date":"2026-07-31","current":-5.37998,"twenty":-12.561192,"median":-10.06542,"eighty":-8.56425,"marketCap":408808522},{"date":"2026-08-07","current":-5.090694,"twenty":-12.489019,"median":-9.881902,"eighty":-8.43493,"marketCap":481925817},{"date":"2026-08-14","current":-5.393903,"twenty":-12.464961,"median":-9.807205,"eighty":-8.177768,"marketCap":510630029},{"date":"2026-08-21","current":-5.202222,"twenty":-12.450318,"median":-9.782121,"eighty":-7.430686,"marketCap":492483973},{"date":"2026-08-28","current":-5.16772,"twenty":-12.413708,"median":-9.712404,"eighty":-6.987812,"marketCap":489217683},{"date":"2026-09-04","current":-4.600344,"twenty":-12.384421,"median":-9.710846,"eighty":-6.276801,"marketCap":435505356},{"date":"2026-09-11","current":-4.048303,"twenty":-12.366639,"median":-9.695292,"eighty":-6.160195,"marketCap":383244713},{"date":"2026-09-14","current":-4.040635,"twenty":-12.362455,"median":-9.690151,"eighty":-6.129859,"marketCap":382518871}],"updateTime":1789496038535},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EVMN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666536463","title":"Evommune股價大跌11.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536463","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536463?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 21:49","pubTimestamp":1788961752,"startTime":"0","endTime":"0","summary":"Evommune股价大跌11.3%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609093869583513.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609093869583513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666389025","title":"BUZZ——美國股市動態-Meta、Chime Financial、ServiceTitan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666389025","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666389025?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 20:09","pubTimestamp":1788955752,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Meta、Chime Financial、ServiceTitan工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB89月9日-周三，受中东局势持续紧张影响，油价自7月以来首次突破市场敏感的每桶100美元关口，加之投资者在等待本周晚些时候","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL4S45112J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0957808578.USD","LU0256863902.USD","LU0985489474.SGD","LU1720051108.HKD","SG9999014898.SGD","SG9999017495.SGD","LU0353189763.USD","LU1064131342.USD","LU1861217088.USD","LU2361044949.HKD","LU2237957811.SGD","SG9999001077.SGD","LU2087621335.USD","LU1988902786.USD","LU0133085943.USD","LU1917777945.USD","OGIG","LU0234570918.USD","CHYM","LU1153585028.USD","SMETAmain","METW","BK4212","LU0642271901.SGD","LU2462157665.USD","IE000MB6IJN5.SGD","IE00BK4W5L77.USD","GAMR","SG9999002224.SGD","IE0004445239.USD","IE0004445015.USD","LU1823568750.SGD","SGXZ51526630.SGD","LU1670711040.USD","LU0316494557.USD","LU0738911758.USD","LU2265009873.SGD","LU1267930730.SGD","LU2756315664.SGD","LU0096364046.USD","LU1316542783.SGD","LU2065171402.SGD","LU1116320901.HKD","LU0889565833.HKD","LU0106261372.USD","LU2125154935.USD","IE00B1XK9C88.USD","LU2592432038.USD","IE00BFSS7M15.SGD","IE00B4JS1V06.HKD","IE0001KFT4U8.USD","LU1839511570.USD","LU1697837992.HKD","IE000ITXATA3.USD","BK4507","LU2360107671.USD","LU0082616367.USD","LU0787776722.HKD","LU0072461881.USD","IE00BJJMRX11.SGD","LU2023250843.SGD","LU2106854487.HKD","LU0210536198.USD","LU0265550359.USD","LU2065169927.USD","BK4585","LU1429558221.USD","LU0912757837.SGD","LU2236285917.USD","LU0203202063.USD","LU0006306889.USD","LU2168564065.EUR","LU1127390331.HKD","LU1670627923.USD","LU2543165471.USD","LU2458330169.SGD","LU2213496289.HKD","HK0000914660.USD","GB00B4QBRK32.GBP","LU0080751232.USD","SG9999015978.USD","LU1059921491.USD","LU1732799900.SGD","IE000YTNTUN2.SGD","LU1670710661.SGD","IE00BQXX3C00.GBP","LU2168564222.USD","LU1791710400.SGD","IE000W1ABFV2.USD","LU2360032135.SGD","LU0077335932.USD","LU1046421795.USD","LU2381873111.SGD","LU1084165304.USD","SGXZ31699556.SGD","LU0203201768.USD","IE00BFSS8Q28.SGD","LU2097829019.USD","METD","SOCL","IE000WAW04H5.SGD","LU2552382058.USD","LU0211328371.USD","LU0208291251.USD","LU0708995401.HKD","LU1074936037.SGD","LU1551013425.SGD","LU0820561909.HKD","METU","LU0068578508.USD","LU0345769128.USD","LU0154236417.USD","LU1280957306.USD","LU2317271919.USD","FXG","LU0109392836.USD","LU1815333072.USD","LU2023250330.USD","LU0149725797.USD","LU0795875169.SGD","LU1267930490.SGD","LU0868494617.USD","LU2602419157.SGD","LU0528227936.USD","TTAN","FBL","LU0170899867.USD","IE0002270589.USD","LU2125154778.USD","LU0672654240.SGD","IE00BJTD4V19.USD","LU0985320562.USD","LU1935042991.SGD","LU0198837287.USD","LU0552385451.USD","LU0096362180.USD","LU0211331839.USD","LU2247934214.USD","IE000F7OJYX1.SGD","IE00BMPRXR70.SGD","BK4215","IE00BK4W5M84.HKD","BK4142","LU2488822045.USD","IE00BWXC8680.SGD","LU1066051498.USD","SG9999014880.SGD","LU2896262040.SGD","LU2347655156.SGD","LU0726765562.USD","LU1564329628.SGD","LU0109391861.USD","LU1974910355.USD","HK0000304797.USD","IE00B4YYXB79.USD","LU0215105999.USD","METV","LU0820561818.USD","LU0011850046.USD","EVMN","IE000SO60NU8.SGD","LU0719512351.SGD","LU0162691827.USD","META","LU1979441026.SGD","LU2272731600.USD","LU2461242641.AUD","LU2463028550.USD","BK4227","LU0061474960.USD","LU0949170772.SGD","SG9999015945.SGD","METG","LU2764263203.CNY","IE00BQXX3D17.EUR","BK4543","BK4023","LU2272731782.SGD","SG9999018865.SGD","SG9999004303.SGD","BK4140","LU1564329032.USD","LU0210528500.USD","SG9999015986.USD","LU1564329461.SGD","LU1366333091.USD","LU1435385759.SGD","LU0788109477.HKD","RSPC","LU1642822529.SGD","LU2357305700.SGD","LU0980610538.SGD","LU1791710582.SGD","LU0210533765.USD","IE00B7KXQ091.USD","LU1066053197.SGD","LU1732800096.USD","LU1778281490.HKD","LU1814569148.SGD","BPAY","LU0203347892.USD","IE00BQXX3F31.USD","LU1242518931.SGD","LU0444973449.USD","GXPC","LU2756315318.SGD","LU0256863811.USD","LU1261432733.SGD","LU0345769631.USD","NULC","LU1935042215.USD","LU0320765059.SGD","SGXZ81514606.USD","IE00B19Z8W00.USD","LU1119994496.HKD","LU0056508442.USD","LU1992135472.HKD","LU2404859667.USD","SG9999015952.SGD","LU0444971666.USD","LU0354030511.USD","LU0061475181.USD","LU1564329115.USD","LU1301847155.USD","XDAT","LU0979878070.USD","LU0353189680.USD","LU1571399168.USD","IE0034235188.USD","LU2063271972.USD","LU2764263039.SGD","IE0000B7K699.USD","LU1718418525.SGD","LU2168564149.EUR","IE000KEQY171.SGD","LU1232071149.USD","LU0072462426.USD","LU2065170008.USD","HK0000914686.HKD","IE00B5949003.HKD","LU2458330243.SGD","IE0005OL40V9.USD","LU0310799852.SGD","LU2322448791.USD","LU1003077747.HKD","LU1366192091.USD","LU0949170426.SGD","LU1868836757.USD","SG9999014914.USD","IE0003U64NQ7.SGD","BK4196","LU0314104364.USD","LU1720051017.SGD","IE00B19Z9505.USD","IE0034235303.USD","LU2250418816.HKD","LU1670711123.USD","IE00B7SZLL34.SGD","LU0878866978.SGD","FCOM","LU0433182093.SGD","IE00BKDWB100.SGD","LU1992135399.USD","LU2505996681.GBP","FBX","LU1804176565.USD","LU0234572021.USD","LU1674673691.USD","LU1861558580.USD","IE00BSNM7G36.USD","FBY","LU2023250504.SGD","LU0784383803.USD","LU2237957902.USD","LU2720916845.USD","LU0689472784.USD","LU1803068979.SGD","IE00B1BXHZ80.USD","LU0061474705.USD","IE0009G5SDU7.USD","LU2133065610.SGD","LU1201861249.SGD","LU0320765489.SGD","LU0265550946.USD","LU2404859741.USD","METQ","LU1868836914.USD","LU0943347566.SGD","LU0784385170.HKD","LU1935043536.SGD","LU2430703178.SGD","LU2360106780.USD","LU1868837136.USD","BK4139","LU2361045086.USD","LU0289739699.SGD","LU1035775433.USD","LU1674673428.USD","FBYY","LU0323591593.USD","TRUC","LU1116320737.USD","BK4077","GB00B4LPDJ14.GBP","LU2746668974.SGD","LU1489326972.SGD","LU0348723411.USD","LU1815336760.USD","LU1551013342.USD","IE00B775H168.HKD","LU2430703251.USD","LU2764262908.HKD","LU0267386448.USD","IE00B19Z3B42.SGD","IE00BN29S564.USD","LU1496350502.SGD","LU1670628061.USD","LU0466842654.USD","LU0784384876.USD","SGXZ99366536.SGD","SG9999014906.USD","LU0211327993.USD","LU0957791311.USD","LTL","BK4524","LU0354030438.USD","LU2272731865.HKD","LU0417517546.SGD","LU1670710588.SGD","LU1935043452.HKD","LU1861559042.SGD","LU2065171311.SGD","IE00B19Z8X17.USD","TH","LU2264538146.SGD","BK4587","SFD","LU0964807845.USD","LU1235294995.USD","LU2746668461.USD","LU0308772762.SGD","LU0690374615.EUR","LU0823421333.USD","LU0683600562.USD","SG9999018857.SGD","LU1699723380.USD","LU1868837300.USD","LU2168564495.EUR","LU2505996509.AUD","SMMT","LU0127658192.USD","LU0690374961.EUR","GB00BDT5M118.USD","IE000BZT7R73.USD","IE00BMPRXN33.USD","LU1242518857.USD","LU0820562030.AUD","IRT","LU0786609619.USD","LU0157215616.USD","LU0097036916.USD","VOX","LU0724617625.USD","LU2473716301.USD","LU0187121727.USD","SG9999002232.USD","LU0545039389.USD","LU2417539215.USD","LU0070302665.USD","LU2552382215.SGD","LU0640476718.USD","LU1145028129.USD","IE00BMPRXQ63.HKD","IE00BJJMRY28.SGD","LU2403377893.USD","IE00BJLML261.HKD","LU0174119429.USD","IE00B19Z3581.USD","LU0053666078.USD","LU0070217475.USD","IE00B3SWFQ91.USD","LU0882574139.USD","LU2456880835.USD","LU1069344957.HKD","IE00BJTD4N35.SGD","LU0130102774.USD","LU0276348264.USD","LU2361044865.SGD","LU2462591350.SGD","IE0009356076.USD","LU0784385840.USD","LU1852331112.SGD","LU0058720904.USD","LU2168563687.JPY","LU1548497426.USD","LU2552382132.HKD","LU2322448957.HKD","INGM","HK0000304805.HKD","LU0203345920.USD","LU1914381329.SGD","LU0553294199.USD","LU0823434740.USD","LU2087625088.SGD","LU1861220207.SGD","LU2244417387.USD","CI","LU1935043023.USD","LU2326559502.SGD","LU0823421416.USD","LU2420271590.USD","LU2347655073.USD","LU0795875086.SGD","LU2430703095.HKD","LU0823434583.USD","LU0225283273.USD","LU0648001328.SGD","SGXZ80539844.SGD","LU1935042488.USD","LU0079474960.USD","LU2860962120.EUR","LU2054465674.USD","LU2487616109.SGD","LU0476273544.USD","LU2242650005.HKD","LU1629891620.HKD","BK4592","SGXZ23171101.USD","LU0661504455.SGD","XLC","LU1868836591.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666583066","title":"Evommune盤前股價下跌18.1%，此前公司研發的濕疹藥物未達到中期試驗主要終點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666583066","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666583066?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 16:06","pubTimestamp":1788941171,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666873308","title":"Evommune因臨床試驗失敗放棄濕疹藥物開發，股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666873308","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666873308?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 06:17","pubTimestamp":1788905848,"startTime":"0","endTime":"0","summary":"Evommune因临床试验失败放弃湿疹药物开发，股价暴跌路透9月8日-Evommune公司周二表示，由于其一款试验性皮肤病药物在中期临床试验中未能达到主要目标，公司将不再推进该药物的研发，受此消息影响，该公司股价在盘后交易中下跌24%。Evommune表示，该药物在所有研究剂量组中均未达到主要或次要研究目标。Evommune表示，其资产负债表预计可为运营提供资金直至2029年，从而支持其旨在广泛应对慢性炎症性疾病的项目组合的推进。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4501P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745998","title":"尼德姆證券首次覆蓋Evommune；股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745998","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745998?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 00:33","pubTimestamp":1787761988,"startTime":"0","endTime":"0","summary":"BUZZ-尼德姆证券首次覆盖Evommune；股价上涨8月26日-** 药物开发商 Evommune（EVMN.N）股价上涨 1.7%，至 14.02 美元** Needham首次覆盖EVMN，给予“买入”评级，目标价28美元** 该券商表示，此评级基于该公司“前景可观的免疫与炎症（I&I）管线，尤其是IL-18抑制剂融合蛋白EVO301，该药物已展现出在特应性皮炎（AD）治疗中与现有生物制剂相当（或更优）的概念验证疗效。”** 补充内容：“即将于9月公布的特应性皮炎IIb期临床试验结果有望为股东创造显著价值”** 自去年11月上市以来，EVMN股价已下跌逾18%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4S44N1DI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647045393","title":"Evommune蕁麻疹藥物2b期研究未達主要終點 將轉向特應性皮炎與偏頭痛","url":"https://stock-news.laohu8.com/highlight/detail?id=2647045393","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647045393?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 03:45","pubTimestamp":1782762300,"startTime":"0","endTime":"0","summary":"生物技术公司Evommune周一公布EVO756治疗中重度慢性自发性荨麻疹的2b期临床试验顶线结果，研究未达到主要疗效终点，公司将停止该适应症的开发，转向特应性皮炎与偏头痛预防领域的探索。公司预计2026年第三季度将公布EVO756治疗特应性皮炎的2b期顶线数据，偏头痛预防的2b期研究已启动患者筛选。 受此消息影响，Evommune股价在周一大幅下跌近40%。有分析人士指出，若CSU研究失败，将进一步降低投资者对特应性皮炎或其他瘙痒相关适应症的信心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-30/doc-inifcmeh1852161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647372070","title":"Evommune股價暴跌，因皮膚病藥物中期試驗失敗","url":"https://stock-news.laohu8.com/highlight/detail?id=2647372070","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647372070?lang=zh_tw&edition=fundamental","pubTime":"2026-06-29 21:47","pubTimestamp":1782740865,"startTime":"0","endTime":"0","summary":"BUZZ-Evommune股价暴跌，因皮肤病药物中期试验失败6月29日-** 药物开发商 Evommune股价下跌 32%，跌至 17.10 美元，创下四个月多以来的新低** 该公司表示，其实验性口服药EVO756在12周后，其降低荨麻疹活动评分的效果并未显著优于安慰剂，未能达到中期临床试验的主要目标** 该公司针对中重度慢性自发性荨麻疹患者开展该药物的临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL4T43114P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180323615","title":"Evommune公布Evo756針對中重度慢性自發性蕁麻疹的2b期試驗頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1180323615","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180323615?lang=zh_tw&edition=fundamental","pubTime":"2026-06-29 20:30","pubTimestamp":1782736249,"startTime":"0","endTime":"0","summary":"Evommune公司宣布了其候选药物Evo756在中重度慢性自发性荨麻疹患者中进行的2b期临床试验的顶线结果。该试验旨在评估Evo756在此类适应症中的疗效与安全性，相关数据为后续临床开发提供了关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149806861","title":"Evommune公司提交招股説明書：現有股東擬轉售最多450萬股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1149806861","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149806861?lang=zh_tw&edition=fundamental","pubTime":"2026-04-18 04:08","pubTimestamp":1776456494,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新备案文件，生物制药公司Evommune已正式提交招股说明书，披露公司现有股东计划转售最多450万股Evommune普通股。\n此次备案文件显示，本次股份转售不涉及公司新发行股份，所有拟出售股份均来自现有股东。该招股说明书的提交标志着股东已获得通过公开市场减持公司股份的资格。\n作为专注于炎症性疾病创新疗法开发的临床阶段生物技术企业，Evommune此次股东股份转售计划受到市场关注。文件未透露具体售股股东身份及股份出售时间安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}